JPS60179658A - Production of protein-bound filter paper - Google Patents

Production of protein-bound filter paper

Info

Publication number
JPS60179658A
JPS60179658A JP9318683A JP9318683A JPS60179658A JP S60179658 A JPS60179658 A JP S60179658A JP 9318683 A JP9318683 A JP 9318683A JP 9318683 A JP9318683 A JP 9318683A JP S60179658 A JPS60179658 A JP S60179658A
Authority
JP
Japan
Prior art keywords
protein
filter paper
bound
reaction
radioimmunoassay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9318683A
Other languages
Japanese (ja)
Inventor
Hidematsu Hirai
平井 秀松
Takayuki Sasaki
孝之 佐々木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP9318683A priority Critical patent/JPS60179658A/en
Publication of JPS60179658A publication Critical patent/JPS60179658A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548Carbohydrates, e.g. dextran

Abstract

PURPOSE:To manufacture protein-bound filter paper which has good sensitivity and accuracy and is adequate for a radioimmunoassay by bringing the carboxyl methyl group of the filter paper consisting of carboxymethyl cellulose and protein into reaction in the presence of a specific condensated matter. CONSTITUTION:Protein-bound filter paper is manufactured by bringing the -OCH2COOH of filter paper consisting of carboxymethyl cellulose and protein such as tumor marker protein 1-ethyl-alpha-fetoprotein or the like, specific antibody, etc. into reaction in the presence of water soluble carbodiimide such as 1-ethyl- 3-(3-dimethyl aminopropyl)-carbodiimide hydrochloride, etc. as a condensating agent. The filter paper obtd. in such a way has high sensitivity and good accuracy and low-non-specific reaction in a radioimmunoassay of alpha-fetoprotein, specific antibody, etc. and is therefore adequate for diagnosing pregnancy and diseases. The condensating agent has no toxicity. The protein-bound filter paper is thus safely obtd.

Description

【発明の詳細な説明】 本発明は、新規蛋白質結合濾紙の製造方法に関する。[Detailed description of the invention] The present invention relates to a method for producing a novel protein-binding filter paper.

今日、多くの有用なラジオイムノアッセイ用の固相法支
持体が用いられている。例えば、セファデックス、セフ
ァロース4B、F紙、ポリスチレンチューブ、ガラスピ
ーズ等などが用いられている。これらのうち、セファデ
ックス、セファロース、濾紙は、いずれも、これらにブ
ロムシアンを結合した後、蛋白質を結合させたものでめ
6゜と仁ろが、かかる方法による場合、製造操作を短時
間で行わなければならず、またブロムシアンは毒性を有
するなどの欠点がある。
Many useful radioimmunoassay solid phase supports are in use today. For example, Sephadex, Sepharose 4B, F paper, polystyrene tubes, glass beads, etc. are used. Among these, Sephadex, Sepharose, and filter paper are all made by bonding bromocyanide and then protein, and the manufacturing process can be completed in a short time using this method. In addition, bromic cyanide has drawbacks such as toxicity.

本発明者らは、ラジオイムノアッセイ用ノ固相法支持体
として、従来用いられていなかったカルホキ多メチルセ
ルロースよりなるF紙を支持体とし、これに蛋白質を縮
合剤の存在下に反H3させて得たものが、ブロムシアン
法で作製した従来の蛋白結合濾紙と同程度の感度及び精
度を有すること見出して本発明を完成するに至った。
The present inventors used F paper made of calhoki polymethylcellulose, which had not been used conventionally, as a support for solid phase method for radioimmunoassay, and obtained the protein by reacting H3 on it in the presence of a condensing agent. The present inventors have completed the present invention by discovering that the filter paper has a sensitivity and accuracy comparable to that of conventional protein-binding filter paper produced by the Bromsian method.

即ち、本発明はカルボキシメチルセルロースよりなる濾
紙のカルボキシメチル基と蛋白質とを縮合剤の存在下に
反F5させることによる蚤白質結合F紙の製造方法より
なるものであり、本製造方法は操作が簡易であり、また
、製造時に使用される試薬は毒性が少なく、シかもラジ
オイムノアッセイ用として極めてすぐれた感度及び精度
を有するものである。
That is, the present invention consists of a method for producing F paper bound to flea white matter by subjecting the carboxymethyl groups of a filter paper made of carboxymethyl cellulose and proteins to anti-F5 in the presence of a condensing agent, and this production method is easy to operate. In addition, the reagents used during production are low in toxicity and have extremely high sensitivity and accuracy for use in radioimmunoassays.

本発明で使用されるF紙は、カルボキシメチルセルロー
ス テアリ、他の成分としてノくインダー、などを含有して
いてもよい。市販品としては、東洋F紙LotNo.2
1260121が例示されるO蛋白質としては、縮合剤
の存在下にカルボキシメチル基と反応しうるアミノ基を
有するものであればよく、通常はラジオイムノアッセイ
におけるマーカー蛋白質として用いられるものが使用さ
れる。蛋白質の例としては、たとえばα−フェトプロテ
ィン、カルシツエン、グリオニ゛ソクアクチゲンなどの
腫瘍マーカー蛋白質、特異抗体などがあげられる。
The F paper used in the present invention may contain carboxymethyl cellulose and other components such as a binder. As a commercially available product, Toyo F Paper Lot No. 2
The O protein, exemplified by 1260121, may be any protein having an amino group that can react with a carboxymethyl group in the presence of a condensing agent, and those used as marker proteins in radioimmunoassay are usually used. Examples of proteins include tumor marker proteins such as α-fetoprotein, calcitene, and gliotinoxactigen, and specific antibodies.

CMF紙と蛋白質との反応は縮合剤の存在下に行われ、
縮合剤としては、l−エチル−3−(3−ジメチルアミ
ノプロビル)−カルボジイミド・Hct@o涼溶・性、
カールl範ジイミド等が例示さnる。
The reaction between CMF paper and protein is carried out in the presence of a condensing agent.
As the condensing agent, l-ethyl-3-(3-dimethylaminoprobyl)-carbodiimide, Hct@olyosol,
Examples include Karl diimides.

本反応においては、CMF紙に縮合剤と蛋白質を同時に
加えてもよいが、CMF紙にまず組合剤を添加して、次
に蛋白質を添加することが好ましい0 本反応においては、まず組合剤によってカルボキシメチ
ルセルロースのカルボキシル基が活性化され、これに蛋
白質のアミン基が反応して酸アミド結合が形成される。
In this reaction, the condensing agent and the protein may be added to the CMF paper at the same time, but it is preferable to first add the combination agent to the CMF paper and then add the protein. The carboxyl group of carboxymethyl cellulose is activated, and the amine group of the protein reacts with it to form an acid amide bond.

反応時のpHI/′i.通常pH4〜5程度であるが、
カルボキシメチルセルローズと縮合剤をまずpH4〜5
程度、就中pH5程度で活性化しておき、次に蛋白質を
加えて、pH7.5〜9程度、就中pH8程度で酸アミ
ド結合を形成させることが好まし・()3かかるApH
で酸アミド結合を形成させた場合、蛋白同志の結合が抑
制され、効率&<、CMF紙のカルボキシル基と蛋白の
アミ7基が反応する。かかるp)lへのm整は、逸材リ
ン酸バッファーなどKよって行われる。
pHI at the time of reaction/'i. Usually pH is around 4-5,
Carboxymethyl cellulose and condensing agent are first adjusted to pH 4-5.
It is preferable to activate the acid amide bond at a pH of about 7.5 to 9, especially about pH 8 after activation at a pH of about 5, especially at a pH of about 5.
When an acid amide bond is formed, the bond between proteins is suppressed, and the carboxyl group of CMF paper and the amine 7 group of the protein react with each other. Such adjustment of p) to l is carried out using a phosphate buffer or the like.

反応時間は、通常4〜6時間程度、好ましくはlO〜1
5時間程度であるがカルボキシル基の活性化は1〜4分
程度、好ましlj:2分程度である。
The reaction time is usually about 4 to 6 hours, preferably 10 to 1
Although the activation time is about 5 hours, the activation of carboxyl groups is about 1 to 4 minutes, preferably lj: about 2 minutes.

以下、実施例を示して本発明をより具体的に説−男する
が、本発明はこれらに限定されるものではない。
EXAMPLES Hereinafter, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited thereto.

実施例1 直径5 mmのCMF紙〔東洋F紙Lot NO−21
260121)ディスク100枚を0.5 NHC46
0rntに45分聞浸してH十型としてから水洗し、こ
れをリン酸バッファー(pH5)6 mtに浸し、l−
エチル−3−(3−ジメチルアミノプロピル)−カルボ
ジイミド塩酸塩2 4 0 tnfを加える。この時、
リン酸バッファーの終濃度は12.57nMとなるよう
にする。2分聞静かに反応漆器を揺った後、抗α−フェ
トプロティン抗体4.8mVをリン酸バッファー(pH
8)8mtに溶かしたものを加える。この際、リン酸バ
ッファーの終濃度は0.2Mになる様にする。12時間
、室温で穏やかに振とうさせ生理食塩水でF紙を洗浄し
て、抗α−フェトプロティン抗体結合CMFMを得た。
Example 1 CMF paper with a diameter of 5 mm [Toyo F Paper Lot NO-21
260121) 100 discs 0.5 NHC46
0rnt for 45 minutes to form an H-type, then washed with water, and immersed in 6 mt of phosphate buffer (pH 5) to form a l-
Add 240 tnf of ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride. At this time,
The final concentration of phosphate buffer is 12.57 nM. After gently shaking the reaction lacquerware for 2 minutes, 4.8 mV of anti-α-fetoprotein antibody was added to phosphate buffer (pH
8) Add the dissolved material to 8mt. At this time, the final concentration of the phosphate buffer should be 0.2M. The F paper was gently shaken at room temperature for 12 hours and washed with physiological saline to obtain anti-α-fetoprotein antibody-bound CMFM.

実施例2 抗α−7エトブロデインを溶かすリン酸バッファとして
pH6のものを用いる他は、実施例1と同様にCて抗α
−フェトプロティン抗体結合CMF紙を得た。
Example 2 Anti-alpha
- Fetoprotein antibody-bound CMF paper was obtained.

実施例3 実施例1において、抗α−フェトプロティン抗体を反F
)させる時間を6時間に短縮するほかは、実施例1と同
様にして抗α−フェトプロティン抗体結合CMF紙を得
た。
Example 3 In Example 1, the anti-α-fetoprotein antibody was
) Anti-α-fetoprotein antibody-conjugated CMF paper was obtained in the same manner as in Example 1, except that the time for the reaction was shortened to 6 hours.

実施例4〜6 実施例1における抗体飯及びカルボジイミド量を下記の
組合せとする#1かは実施例1と同様にして抗α−フェ
トプロティン抗体結合CMF紙を得た。
Examples 4 to 6 Anti-α-fetoprotein antibody-bound CMF paper was obtained in the same manner as in Example 1 except for #1 in which the amounts of antibody and carbodiimide in Example 1 were set as shown below.

4 4、8mW 240r1 5 4、8mlF ctotn9 6 2、 4 mW 6 0 mW 参考例1 実施例1において、カルボジイミドを加えないこと及び
アミド結合形成時間を6時間とするほかは実施例IK準
する操作を行った。
4 4, 8 mW 240r1 5 4, 8 mlF ctotn9 6 2, 4 mW 6 0 mW Reference Example 1 The same procedure as Example IK was carried out in Example 1 except that carbodiimide was not added and the amide bond formation time was changed to 6 hours. went.

参考例2 tit径5 mmの東洋pl#.No. 5 1を用い
、Ceska5 (Immunochem、 9.10
21.(1972))に記載の方法に準するブロムシア
ン法によって抗α−フェトプロティン抗体結合CMF紙
を得た。
Reference example 2 Toyo pl#. tit diameter 5 mm. No. 51 using Ceska5 (Immunochem, 9.10
21. (1972)), anti-α-fetoprotein antibody-bound CMF paper was obtained by the Bromsian method.

参考例8 参考例2において、ブロムシアンを用いない以外は参考
例2に準する操作を行った。
Reference Example 8 In Reference Example 2, the same operation as in Reference Example 2 was performed except that bromcyan was not used.

実施例及び参考例によって得られた蛋白質結合ディスク
について以下の実験を行った。
The following experiments were conducted on the protein-binding disks obtained in Examples and Reference Examples.

なお、以下の実験において、ラジオイムノアッセイは次
の如き方法によって行った。
In addition, in the following experiments, radioimmunoassay was performed by the following method.

(ラジオイムノアッセイ) 組織培養plateのwell に実施例1の抗α−フ
ェトプロティン抗体結合ディスク(又は実施例2゜8.
4,5.6、参考例1.2.8のディスク)を入れ次に
種々の濃度のα−フェトプロjイン(10チ正常ウマ血
清で調gり又は妊婦血清o、1mt入れる。(doab
leで行なう)室温で8時間振とり後吸引にてwell
内の液を除去する。生理食塩液250μを加え1分間振
とうし濾紙を洗浄する(3回行なう)。ヨードラベル抗
α−フェトプロティン抗体0.1mt (カウント数=
Tとする)加え室温で約24時間静かに振とうする。生
理賞塩液250μt 添加しlO0分間振うしてから吸
引洗浄する(8回行なう)。濾紙を試験管に移しカウン
ト数を測定する(カウント数−Bとする。 B/TX 
I OO= B/T%)。
(Radioimmunoassay) The anti-α-fetoprotein antibody binding disk of Example 1 (or Example 2.8.
4, 5.6, the disk of Reference Example 1.2.8) and then add α-fetoproin of various concentrations (1 mt prepared with normal horse serum or pregnant women's serum).
After shaking at room temperature for 8 hours, vacuum the well.
Remove the liquid inside. Add 250μ of physiological saline and shake for 1 minute to wash the filter paper (this is done 3 times). Iodolabeled anti-α-fetoprotein antibody 0.1 mt (number of counts =
T) and shake gently at room temperature for about 24 hours. Add 250 μt of physiological saline solution, shake for 100 minutes, and then wash by suction (do this 8 times). Transfer the filter paper to a test tube and measure the count (count number - B. B/TX
IOO=B/T%).

実験例1 実施例1と実施例2で得られたものによるラジオイムノ
アッセイの感度を対比し、その結果を第1図にグラフト
として示した。第1図においてΔは実施例1のものを、
口は実施例2のものをボす。
Experimental Example 1 The sensitivities of the radioimmunoassays obtained in Example 1 and Example 2 were compared, and the results are shown as a graft in FIG. In FIG. 1, Δ is that of Example 1,
The opening is similar to that of Example 2.

この結果から明らかなように、実施例1のものは10n
r付近の濃度まで測定可能でるる。
As is clear from this result, in Example 1, 10n
It is possible to measure concentrations up to around r.

実験例2 実施例3と参考例2で得られたものによるラジオイムノ
アッセイの検量線を比較して第2図にグラフとして示し
た。第2図において△は実施例3のものを、ムは参考例
のものを、○は参考例2のものを、・は参考例8のもの
を示す。
Experimental Example 2 The calibration curves of the radioimmunoassays obtained in Example 3 and Reference Example 2 were compared and shown as a graph in FIG. In FIG. 2, △ indicates that of Example 3, M indicates that of Reference Example, ○ indicates that of Reference Example 2, and . indicates that of Reference Example 8.

この結果から明らかなように参考例2のブロムシアン法
はB/T (チ)#′i高いが非特異的吸着も高い、一
方実施例3のものはB/T (%)は低いが、非特異反
応も低い。
As is clear from this result, the Bromsian method of Reference Example 2 has a high B/T (ch) Specific reactions are also low.

実験例3 実施例4〜6で得られたものによるラジオイムノアッセ
イの検量線を第3図にグラフとして示した。第8図にお
いて△は実施例4のものを、○は実施例5のものを、×
は実施例6のものを示す。
Experimental Example 3 The calibration curve of the radioimmunoassay obtained in Examples 4 to 6 is shown as a graph in FIG. In Fig. 8, △ is for Example 4, ○ is for Example 5, ×
shows that of Example 6.

この結果から明らかなように、本発明方法において、蛋
白質量及びカルボジイミド量を比較的少ない量で用いて
も、十分使用に耐えうるものが得られる。
As is clear from this result, in the method of the present invention, even if relatively small amounts of protein and carbodiimide are used, a product that can be used sufficiently can be obtained.

実験例4 実施例6で得られたものVこついて、α−フェトプロテ
ィン濃度が、O−10Ont/ml 、100−20 
Q nff/mL及び200−800nl/mtに該当
する妊婦血清kX4 、X8 、X16に希釈していき
、そのラジオイムノアッセイ検量線をプロットしていっ
て第4図にグラフとして示した。第4図において、Δは
200〜300nr/mtk、Oは10O−200nf
/mt f、XはO−10On?/mLを示すものであ
る。この結果から明らかなように希釈試験においても、
はぼ満足する直線性を示した。
Experimental Example 4 The α-fetoprotein concentration obtained in Example 6 was O-10 Ont/ml, 100-20
The serum was diluted into pregnant women's serum kX4, X8, and X16 corresponding to Qnff/mL and 200-800 nl/mt, and the radioimmunoassay standard curve was plotted and shown as a graph in FIG. In Figure 4, Δ is 200-300nr/mtk, O is 10O-200nf
/mt f, X is O-10On? /mL. As is clear from this result, even in the dilution test,
It showed satisfactory linearity.

実験例5 妊婦血清11例について参考例2によるα−フェトプロ
ディ/の検量線と実施例6によるα−7エトブロjイ/
の検:it!それぞれからα−フエI・プロティン含有
量を氷め相関を氷めた所V=0.97゜Y=0.92X
+7.79となり、有tな相関が認められた(図5参照
)。
Experimental Example 5 Calibration curve of α-fetbrodi/ according to Reference Example 2 and α-7 ethobrodi / according to Example 6 for 11 pregnant women's serum
Inspection: it! The correlation between α-Fue I and protein content is calculated from each of them: V = 0.97° Y = 0.92X
+7.79, indicating a significant correlation (see Figure 5).

【図面の簡単な説明】[Brief explanation of the drawing]

第1因は、本発明の蛋白結合P#:、を用いるラジオイ
ムノアッセイ図を、第2図は本発明蛋白結合濾紙と従来
濾紙とのラジオイムノアッセイ比較図を、第3図は蛋白
量、組合剤の量を変えた場合のラジオイムノアッセイ図
を、第4図は本発明濾紙による連続希釈検体についての
ラジオイムノアッセイ検i1に、m、を、第5図は本発
明濾紙と従来濾紙との相関性を調べた図である。 第1図 AFP nq/m+ 第5図 杢化明シ上 手続−?cni正書(自発) 昭和58年8月M日 1、事件の表示 昭和58年特許願第093186号 2、発明の名称 蛋白結合5戸紙の製造方法 3、補正をする者− 事件との関係 特許出願人 氏名(名称) 平 井 秀 松 4、代理人 ■541 住 所 大阪市東区平野町4丁目53番地3ニューライ
フ平野町406号 電話(06) 227−1156 代理権を証明する書面 (1) IJ1細!第3頁、第1z行の「カルシツエン
、プリオニツクアクチグンJt「カルンノ二ングリオニ
ツクア/チゲ7」に訂正アゐ。 (2)明細書第7頁、下から第4行の[doable 
Jp r double Jに訂正T/)。 (3)明細書第8頁、第10行の「クラフトとして」髪
「グラフトして」に訂正子り。 (4)委任状ケ提出T/)。
The first factor is a radioimmunoassay diagram using the protein-bound P# of the present invention, Figure 2 is a comparison diagram of a radioimmunoassay between the protein-bound filter paper of the present invention and a conventional filter paper, and Figure 3 is a diagram showing the amount of protein and the combination agent. Figure 4 shows the radioimmunoassay test i1 and m for serially diluted samples using the filter paper of the present invention, and Figure 5 shows the correlation between the filter paper of the present invention and the conventional filter paper. This is the diagram I investigated. Fig. 1 AFP nq/m+ Fig. 5 Mold formation procedures -? cni official document (spontaneous) August M, 1988 1, Indication of the case 1988 Patent Application No. 093186 2, Name of the invention Process for manufacturing protein-bonded 5-sheet paper 3, Person making the amendment - Relationship to the case Patent Applicant Name Hide Hirai Matsu 4, Agent ■541 Address 406 New Life Hirano-cho, 4-53-3 Hirano-cho, Higashi-ku, Osaka Telephone: (06) 227-1156 Document proving power of attorney (1) ) IJ1 thin! I have corrected the ``Calcitsuen, Prionik Actigun Jt ``Karunno Nigurionikkua/Chige 7'' on page 3, line 1z. (2) [double] on page 7 of the specification, 4th line from the bottom
Jpr double J corrected T/). (3) On page 8, line 10 of the specification, there is a correction to "as a craft" and "grafted" the hair. (4) Submit power of attorney T/).

Claims (3)

【特許請求の範囲】[Claims] (1) カルボキシメチルセルロースよりなる濾紙のカ
ルボキシメチル基と蛋白質とを縮合剤の存在下に反応さ
せることを特徴とする蛋白質結合濾紙の製造方法。
(1) A method for producing a protein-bound filter paper, which comprises reacting carboxymethyl groups of a filter paper made of carboxymethyl cellulose with a protein in the presence of a condensing agent.
(2)縮合剤が水だ性カルボシイミド試薬である特許請
求の範囲第(0項記載の製造方法。
(2) The manufacturing method according to claim 0, wherein the condensing agent is a water-soluble carbosiimide reagent.
(3)蛋白質が、腫瘍マーカー蛋白質である特許請求の
範囲第(1)項又は第(2)項記載の製造法。
(3) The production method according to claim (1) or (2), wherein the protein is a tumor marker protein.
JP9318683A 1983-05-26 1983-05-26 Production of protein-bound filter paper Pending JPS60179658A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9318683A JPS60179658A (en) 1983-05-26 1983-05-26 Production of protein-bound filter paper

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9318683A JPS60179658A (en) 1983-05-26 1983-05-26 Production of protein-bound filter paper

Publications (1)

Publication Number Publication Date
JPS60179658A true JPS60179658A (en) 1985-09-13

Family

ID=14075542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9318683A Pending JPS60179658A (en) 1983-05-26 1983-05-26 Production of protein-bound filter paper

Country Status (1)

Country Link
JP (1) JPS60179658A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01239148A (en) * 1988-01-27 1989-09-25 Boehringer Mannheim Gmbh Separably immersed support fleece for reagent and impregnation of support fleece

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01239148A (en) * 1988-01-27 1989-09-25 Boehringer Mannheim Gmbh Separably immersed support fleece for reagent and impregnation of support fleece
JPH0359383B2 (en) * 1988-01-27 1991-09-10 Boehringer Mannheim Gmbh

Similar Documents

Publication Publication Date Title
CA2687178C (en) Polymeric carriers for immunohistochemistry and in situ hybridization
JP2731739B2 (en) Quaternary ammonium immunogen conjugates and immunoassay reagents
JP4920415B2 (en) Probe complex
JPH0535990B2 (en)
JP5808808B2 (en) Non-specific reaction inhibitor, non-specific reaction suppression method and kit
JPS59206765A (en) Urea coupled immunogen composite body, antibody thereof and manufacture thereof
JPS60179658A (en) Production of protein-bound filter paper
WO2018006268A1 (en) Acridine-marker conjugate and preparation method thereof, and chemiluminescence kit
US4623629A (en) Solid-phase immunoassay support and method of use thereof
JP4746810B2 (en) Method for immobilizing an affinity reagent on a hydrophobic solid phase
WO2018006264A1 (en) Acridine marker conjugate and preparation method therefor and chemiluminescent kit
CN114252591A (en) Magnetic bead coating and preparation method thereof and detection kit
JPS6210070A (en) Histamine derivative, immunogenic conjugate and antibody raised against same
JPS6020149A (en) Immunochemical measurement method and its reagent
JPS587560A (en) Reagent for measuring copper, zinc-super oxidedismutase
CN113721012B (en) Composition and application of kit thereof in detection of glycocholic acid
JPH081433B2 (en) Hapten immunoassay
JPS5880558A (en) Immunochemical measuring reagent
JPH0694709A (en) Reagent for measuring free thyroid gland hormone and its measuring method
JPS63222257A (en) Immunosensor for simultaneous measurement of multiple antigen
JPS60123765A (en) Preparation of peculiar antibody to vanylmanderic acid
JPS63315954A (en) Labeled antibody for immunoassay and immunoassay using said antibody
JPS59224563A (en) Reagent composition and method for measuring enzyme immunity of human chorionic gonandotropin
JPH07234222A (en) Quantitative analysis method for 1,5-anhydroglucitol and antibody
JPH03144366A (en) Immune measurement